###begin article-title 0
###xml 93 101 93 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 113 121 113 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 137 143 <span type="species:ncbi:10090">murine</span>
###xml 153 158 <span type="species:ncbi:9606">human</span>
###xml 159 165 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
Restriction by APOBEC3 proteins of endogenous retroviruses with an extracellular life cycle: ex vivo effects and in vivo "traces" on the murine IAPE and human HERV-K elements
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 330 336 <span type="species:ncbi:10090">murine</span>
APOBEC3 cytosine deaminases have been demonstrated to restrict infectivity of a series of retroviruses, with different efficiencies depending on the retrovirus. In addition, APOBEC3 proteins can severely restrict the intracellular transposition of a series of retroelements with a strictly intracellular life cycle, including the murine IAP and MusD LTR-retrotransposons.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 232 240 232 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 374 384 374 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In silico </italic>
###xml 134 168 <span type="species:ncbi:45617">human endogenous retrovirus HERV-K</span>
###xml 192 198 <span type="species:ncbi:10090">murine</span>
###xml 203 208 <span type="species:ncbi:9606">human</span>
###xml 493 498 <span type="species:ncbi:10090">mouse</span>
###xml 503 508 <span type="species:ncbi:9606">human</span>
###xml 591 597 <span type="species:ncbi:10090">murine</span>
###xml 610 615 <span type="species:ncbi:9606">human</span>
Here we show that the IAPE element, which is the infectious progenitor of the strictly intracellular IAP elements, and the infectious human endogenous retrovirus HERV-K are restricted by both murine and human APOBEC3 proteins in an ex vivo assay for infectivity, with evidence in most cases of strand-specific G-to-A editing of the proviruses, with the expected signatures. In silico analysis of the naturally occurring genomic copies of the corresponding endogenous elements performed on the mouse and human genomes discloses "traces" of APOBEC3-editing, with the specific signature of the murine APOBEC3 and human APOBEC3G enzymes, respectively, and to a variable extent depending on the family member.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 41 47 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
These results indicate that the IAPE and HERV-K elements, which can only replicate via an extracellular infection cycle, have been restricted at the time of their entry, amplification and integration into their target host genomes by definite APOBEC3 proteins, most probably acting in evolution to limit the mutagenic effect of these endogenized extracellular parasites.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 607 608 607 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 651 652 651 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 695 696 695 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 946 948 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1096 1098 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1263 1264 1263 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1526 1528 1526 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1529 1531 1529 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 2270 2272 2270 2272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 2273 2275 2273 2275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 2450 2452 2450 2452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 2514 2516 2514 2516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 2517 2519 2517 2519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2703 2711 2703 2711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 2937 2938 2937 2938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 2939 2941 2939 2941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 2942 2944 2942 2944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 2990 2992 2990 2992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 3007 3011 3007 3011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 3026 3028 3026 3028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 3139 3141 3139 3141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 3142 3144 3142 3144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 3145 3147 3145 3147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 3217 3221 3217 3221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 3231 3233 3231 3233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 3234 3236 3234 3236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 3254 3258 3254 3258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 3333 3335 3333 3335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 3430 3432 3430 3432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 3433 3435 3433 3435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 3565 3567 3565 3567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 3568 3570 3568 3570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 3571 3573 3571 3573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 3589 3599 3589 3599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 3749 3751 3749 3751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 3764 3766 3764 3766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 3830 3838 3830 3838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 207 212 <span type="species:ncbi:9606">human</span>
###xml 254 257 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 294 299 <span type="species:ncbi:9606">Human</span>
###xml 555 560 <span type="species:ncbi:9606">human</span>
###xml 841 844 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 846 849 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 882 899 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 904 926 <span type="species:ncbi:272636">adeno-associated virus</span>
###xml 967 973 <span type="species:ncbi:9606">humans</span>
###xml 979 984 <span type="species:ncbi:10090">mouse</span>
###xml 1044 1049 <span type="species:ncbi:9606">human</span>
###xml 2171 2177 <span type="species:ncbi:10090">murine</span>
###xml 2383 2389 <span type="species:ncbi:10090">murine</span>
###xml 2463 2497 <span type="species:ncbi:45617">human endogenous retrovirus HERV-K</span>
###xml 2909 2914 <span type="species:ncbi:9606">human</span>
###xml 3001 3006 <span type="species:ncbi:9606">human</span>
###xml 3400 3406 <span type="species:ncbi:10090">murine</span>
###xml 3507 3513 <span type="species:ncbi:10090">murine</span>
###xml 3541 3546 <span type="species:ncbi:9606">human</span>
###xml 3673 3679 <span type="species:ncbi:10090">murine</span>
The APOBEC family of cytosine deaminases includes numerous members that can deaminate cytosine to uracil within DNA and/or RNA molecules. Among these enzymes, the APOBEC3 sub-family has been discovered when human APOBEC3G (hA3G) was reported to restrict HIV replication ([1]; reviewed in [2]). Human hA3G has been shown to trigger extensive deamination of cytosine in the negative viral DNA strand during reverse transcription and to lead to deleterious G-to-A mutations considered as the hallmark of APOBEC3-editing activity. Subsequently, several other human APOBEC3 proteins - including APOBEC3A (hA3A) [3], APOBEC3B (hA3B) [4,5], APOBEC3C (hA3C) [5], APOBEC3DE (hA3DE) [6], APOBEC3F (hA3F) [7-9] and APOBEC3H (hA3H) [10] - have been shown to exhibit antiviral effects against a variety of viruses, including numerous retroviruses - i.e. HIV, SIV, MLV, HTLV and foamy viruses -, hepatitis B virus and adeno-associated virus (AAV) (for review [11]). In contrast to humans, the mouse genome encodes only one APOBEC3 (mA3) protein, which, like human APOBEC3 proteins, displays antiviral effects [12]. Aside from the antiviral function of APOBEC3 proteins against exogenous viruses, some inhibitory effects have been reported on intracellular targets (for review [2]) and several studies support the notion that the primary function of APOBEC3 proteins could be to prevent the propagation of mobile elements. Indeed, mammalian genomes have accumulated numerous transposable elements which account for > 45% of the genomic DNA [13,14]. These elements can be grouped into two main classes: the strictly intracellular non-LTR (Long Terminal Repeat) retrotransposons, namely long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), which account for ~30% of each mammalian genome, and the LTR-containing retroelements (including the endogenous retroviruses, ERVs), accounting for ~10% of the genomes and closely related to retroviruses. The life cycle of ERVs includes the formation of virus-like particles (VLPs) that, in several instances - but not systematically - can remain strictly intracellular as observed for the well-characterized murine intracisternal A-particle (IAP) and MusD elements (the so-called "intracellularized" ERVs, [15-18]), or that can bud at the cell membrane for an extracellular cycle as observed for the recently identified murine intracisternal A-particle-related envelope-encoding (IAPE; [18]) and the human endogenous retrovirus HERV-K(HML2) elements [19,20]. Although most of these elements are no longer active due to the accumulation of inactivating mutations, some of them are still functional and have been cloned, thus allowing direct ex vivo assay of the effect of APOBEC proteins on their mobility. Accordingly, several APOBEC3 proteins, including hA3A, hA3B, hA3C and hA3F have been demonstrated to restrict the retrotransposition of the human LINE-1 (L1) elements [3,21,22], as well as the L1-dependent transposition [23] of the human Alu SINE elements [24]. Moreover, although no effect on the retrotransposition of L1 elements was observed in the presence of hA3G [21,25-27], reports have shown that hA3G can prevent the retrotransposition of Alu elements [27,28] by sequestering Alu RNAs in cytoplasmic high-molecular-mass (HMM) ribonucleoprotein complexes [28]. Similarly, the cloning of active copies for the intracellular murine IAP and MusD elements [15,17] made possible to demonstrate susceptibility of these retroelements to murine APOBEC3 and to most of the human APOBEC3 proteins [24,26,29]. In addition, in silico analyses of the naturally present genomic copies of these elements in the murine genome have revealed "traces" of APOBEC3 editing on these elements ([26]; see also [30]), thus supporting the physiological relevance of the observed ex vivo assays, and the genomic impact of APOBEC3 protein activity.
###end p 9
###begin p 10
###xml 181 191 181 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 559 567 559 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phoenix </italic>
###xml 596 606 596 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 958 966 958 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 986 996 986 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 1401 1410 1401 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de facto </italic>
###xml 1479 1489 1479 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bona fide </italic>
###xml 191 197 <span type="species:ncbi:10090">murine</span>
###xml 461 466 <span type="species:ncbi:9606">human</span>
###xml 485 491 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 776 781 <span type="species:ncbi:9606">human</span>
###xml 816 821 <span type="species:ncbi:9606">human</span>
###xml 826 832 <span type="species:ncbi:10090">murine</span>
###xml 1294 1300 <span type="species:ncbi:9606">humans</span>
###xml 1305 1309 <span type="species:ncbi:10090">mice</span>
Here we take advantage of the recent identification of the infectious progenitor of the intracellularized IAP retrotransposon, namely IAPE, to analyze the possible restriction of a bona fide murine ERV, in a state close to that at the time of its initial endogenization step when the element still behaved as an infectious retrovirus, having not yet reached its highly adapted "intracellularized" state [18]. In parallel, we performed a similar analysis on the human progenitor of the HERV-K(HML2) family members that we had "reconstituted", resulting in the Phoenix element which proved to be a bona fide endogenous retrovirus, the element being able to enter cells by infection and integrate with all the characteristic features of the genomic copies presently found in the human genome [19]. These two functional human and murine "extracellular" ERVs were used to assess the effects of APOBEC3 proteins on mammalian endogenous retroviruses in appropriate ex vivo assays, and refined in silico analyses of the naturally present copies of these elements in their target host genomes finally unambiguously demonstrated "traces" of APOBEC3 editing, with identifiable signatures. Altogether, the data show that APOBEC3 proteins play a role not only on the intracellular retrotransposons found in humans and mice, but also on their retroviral "progenitors" endowed with an extracellular life style, thus de facto filling the gap between the described effects of APOBEC3 proteins on bona fide exogenous retroviruses on the one hand and intracellular retroelements on the other.
###end p 10
###begin title 11
Results and discussion
###end title 11
###begin title 12
###xml 15 21 <span type="species:ncbi:10090">murine</span>
###xml 26 31 <span type="species:ncbi:9606">human</span>
Restriction of murine and human infectious ERVs by APOBEC3 proteins
###end title 12
###begin p 13
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 331 335 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 436 444 436 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phoenix </italic>
###xml 511 515 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 614 615 614 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1289 1291 1278 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R </sup>
###xml 1346 1347 1335 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1461 1463 1450 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1743 1746 1732 1735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e</italic>
###xml 1772 1773 1761 1762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
###xml 237 240 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 387 393 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 484 487 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 647 653 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 771 777 <span type="species:ncbi:10090">murine</span>
###xml 787 792 <span type="species:ncbi:9606">human</span>
###xml 1433 1439 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 1485 1491 <span type="species:ncbi:10090">murine</span>
###xml 1563 1568 <span type="species:ncbi:9606">human</span>
###xml 1795 1800 <span type="species:ncbi:9606">human</span>
###xml 1801 1807 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 1851 1857 <span type="species:ncbi:10090">murine</span>
To assay whether the mouse IAPE element is restricted by APOBEC3 proteins, we used the previously described functional copy of IAPE-D (; mm9 July 2007 Assembly: chr12: 24,282,555-24,290,874) [18] that was cloned under the control of the CMV promoter, and in which a neo resistance gene was inserted in reverse orientation into the env gene (Figure 1A). The effect of APOBEC3 proteins on HERV-K was analyzed by using the "reconstituted" Phoenix element cloned under the control of the CMV promoter, in which the env gene is stopped and an anti-sense-oriented neo resistance gene is inserted into its 3'-LTR (Figure 1). Proviral clones of IAPE-D or HERV-K (4.5 mug), complemented with an expression vector for a functional IAPE or VSV-G Env (0.5 mug) respectively, and the murine (mA3) or human (hA3A-G) APOBEC3 proteins or a control plasmid (5 mug), were transfected in 293T cells. Supernatants were harvested 48 h post-transfection, filtered through 0.45-mum pore-size PVDF membranes, supplemented with Polybrene (4 mug/ml), and transferred onto HeLa target cells. To increase sensitivity, target cells were subjected to spinoculation at 1.200 x g for 2.5 h at 25degreesC. Infection events were detected after G418 selection of target cells and viral titers expressed as the number of G418R clones per mL of supernatant. As illustrated in Figure 1, mA3 and hA3G protein expression leads to a dramatic decrease in both the IAPE-D and HERV-K viral titers (Figure 1B). In the case of the murine IAPE-D element, only a limited effect - if any - was observed with the human APOBEC3 proteins other than hA3G, with for instance no effect of hA3A which otherwise has a strong effect on the rate of retrotransposition of its intracellular counterpart, i.e. the IAP element (Figure 1). In the case of the human HERV-K, at variance with what is observed for the murine IAPE-D element, almost all the APOBEC3 proteins (with the exception of hA3C) have an effect, the highest activity being observed with hA3B and hA3F.
###end p 13
###begin p 14
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 368 372 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 931 933 931 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R </sup>
###xml 1162 1166 1160 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 1205 1207 1203 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1394 1396 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1567 1570 1563 1566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3 </sup>
###xml 1574 1576 1570 1572 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R </sup>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 207 213 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 456 461 <span type="species:ncbi:9606">Human</span>
###xml 722 728 <span type="species:ncbi:10090">murine</span>
###xml 733 738 <span type="species:ncbi:9606">human</span>
###xml 958 964 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
Murine and human APOBEC3 proteins inhibit endogenous retroviruses. (A) Rationale of the assay for detection of infection events by endogenous retroviruses in the presence of APOBEC3 proteins. The IAPE-D and HERV-K elements used in the assay are marked with the neo reporter gene - inserted in reverse orientation - and carry their own functional genes, except for the env gene which is supplied in trans, thus allowing only for single rounds of infection. Human 293T cells are co-transfected with the indicated expression vectors for APOBEC3 family members, the supernatants collected 2-days post-transfection to infect HeLa target cells, and infection events detected upon G418 selection. (B) Analysis of the activity of murine and human APOBEC3 proteins on the indicated endogenous retroviruses. Viral titers are given as percentages relative to a control (no apobec: expression vector with a nonfunctional hA3G; 622 and 549 G418R clones/ml for IAPE-D and HERV-K, respectively). Data are the means +/- standard deviations (s.d.) for at least three independent experiments. Bottom: retrotransposition frequency of an active autonomous IAP element marked with a neo indicator gene for retrotransposition [17] in the presence of the corresponding APOBEC3 proteins; the assay was performed by cotransfection of HeLa cells with the marked IAP and APOBEC expression vector as previously described [26]; values are the means +/- standard deviations (s.d.) for at least three independent experiments and are given as percentages relative to the control (no apobec; 1.3 x 10-3 G418R clones/cell).
###end p 14
###begin p 15
###xml 158 166 158 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 253 255 253 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R </sup>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 670 671 670 671 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 677 678 677 678 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 830 831 830 831 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 842 843 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 964 965 964 965 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 990 991 990 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1093 1097 1093 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 187 193 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 426 432 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
We further assessed whether the observed decrease in viral titers was associated with editing of the viral DNA by sequencing a 800 or 1600 bp fragment of the de novo integrated IAPE-D or HERV-K proviral DNA copies, respectively, in 20-25 individual G418R clones. As illustrated in Figure 2 numerous G-to-A transitions were observed in the presence of mA3 or hA3G in both ERVs, as expected for an APOBEC3-mediated editing. For HERV-K, G-to-A editing was also observed with hA3B, hA3DE and hA3F, but not with hA3A, as expected from previous characterization of this enzyme ([3,21,24,29]; reviewed in [11]). Furthermore, mA3 and hA3G editing leads to G-to-A mutations in a GXA or GG context, respectively, which are the hallmarks previously described for each enzyme [26,31,32]. For hA3B and hA3F, G-to-A editing was observed in the GA context [2,33]. In addition, in spite of a low number of G-to-A mutations, hA3DE editing seems to preferentially take place in the GA/T context as expected [6]. It has to be stressed that the editing rate is probably underestimated because too heavily mutated neo genes present in these ERV DNAs can no longer confer G418 resistance after integration.
###end p 15
###begin p 16
###xml 186 192 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
APOBEC3 proteins induce specific G-to-A hypermutations. Two-entry tables showing nucleotide substitution preferences in the presence of the indicated APOBEC3 proteins for the IAPE-D and HERV-K integrated proviruses. n, total number of bases sequenced. The adjacent graphs represent the relative frequencies of observed G-to-A mutations as a function of the G neighboring nucleotides (+2 position for the expected mA3 footprint, +1 position for the other APOBEC3s); for the two-entry tables, p-values calculated by a Poisson regression in a log-linear model for the occurrence of the G-to-A versus C-to-T mutations yielded p < 0.03 in all cases (except for hA3DE (p = 0.18) due to the low number of mutations); for the adjacent graphs, p-values calculated by a chi square test were p < 0.01 in all cases (except again for hA3DE, p = 0.7); similar levels of significance (or even higher) were obtained using the Kruskal Wallis test.
###end p 16
###begin title 17
###xml 53 59 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 76 82 <span type="species:ncbi:10090">murine</span>
###xml 87 92 <span type="species:ncbi:9606">human</span>
Traces of APOBEC3 past activity on resident IAPE and HERV-K elements in the murine and human genome
###end title 17
###begin p 18
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 196 204 196 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 390 400 390 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 995 997 995 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1167 1177 1167 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 1442 1450 1442 1450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 1710 1712 1710 1712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 2509 2511 2509 2511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 2633 2634 2633 2634 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 2748 2750 2748 2750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 2809 2810 2809 2810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 2856 2857 2856 2857 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 2882 2884 2882 2884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 2885 2887 2885 2887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 2888 2890 2888 2890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 2994 2995 2994 2995 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 3026 3028 3026 3028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 3083 3085 3083 3085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 3106 3107 3106 3107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 3172 3173 3172 3173 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 3179 3180 3179 3180 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 3391 3392 3391 3392 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 3415 3417 3415 3417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 3695 3697 3695 3697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 3836 3846 3836 3846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 10 16 <span type="species:ncbi:10090">murine</span>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 38 44 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 335 341 <span type="species:ncbi:10090">murine</span>
###xml 346 351 <span type="species:ncbi:9606">human</span>
###xml 603 609 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 629 635 <span type="species:ncbi:10090">murine</span>
###xml 661 666 <span type="species:ncbi:9606">human</span>
###xml 667 673 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 1399 1405 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 2004 2010 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 2944 2950 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 3340 3346 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 3625 3631 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 3886 3892 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
Since the murine IAPE-D and the human HERV-K elements are found to be restricted by APOBEC3 proteins in the ex vivo assay above, we asked whether APOBEC3 proteins might have actually impaired the in vivo amplification of these elements in the past, by searching for evidence of APOBEC3-editing on the endogenous copies residing in the murine and human genome, respectively. Accordingly, an in silico analysis was performed to assess the levels of G-to-A mutations in two sets of full-length genomic IAPE elements, originating from two different subfamilies, namely IAPE-A and IAPE-D, and on full-length HERV-K elements. Both the murine IAPE-D subfamily and the human HERV-K elements have most probably been amplified by reinfection of the germline and therefore could have been subjected to APOBEC3 editing. Conversely, the IAPE-A subfamily has most probably been amplified via gene duplication, with several elements - essentially on the Y chromosome - disclosing identical flanking sequences [34,35], and therefore should not have undergone APOBEC3 editing: this family of elements - closely related to IAPE-D - can therefore be used as an internal control for the in silico genomic analyses. For all three families of elements, we selected by BLAST analysis a set of twenty copies displaying the closest sequence similarity to their cognate "master" copy: to the functional "Phoenix" element for HERV-K, to the functional copy used in the ex vivo assay for IAPE-D, and to the unique full-length copy with preserved open reading frames for IAPE-A. A consensus sequence was then derived for each family of elements, and each family member was analyzed for mutations to the consensus. As illustrated in Figure 3A, numerous mutations can be found for the three families of elements, consistent with the million years of genome evolution that have elapsed since the initial infection and/or amplification events. However, a specific increase in G-base mutations can be observed for both the IAPE-D and the HERV-K copies, not observed for the IAPE-A copies. These mutations are essentially G-to-A substitutions, with the effect being most probably "strand-specific", since the number of such mutations is almost twice that of the C-to-T substitutions. In addition, this bias is not observed for the IAPE-A elements, as expected for a duplicated element which has amplified by chromosomal DNA duplication, without a reverse transcription step prone to APOBEC3 mutagenesis. Interestingly, as illustrated in Figure 3B, the observed G-to-A changes are not randomly distributed but seem to be influenced by the neighbouring nucleotides: the GXA triplet is the most frequent "target" for the G-to-A substitutions in the IAPE-D elements (see arrow in Figure 3B), in agreement with previous reports - and data in Figure 2 - indicating that mA3 preferentially targets GXA trinucleotide motifs [26,31,33]. On the other hand, the G-to-A substitutions in the HERV-K copies are most frequently observed in the GG context (see arrow in Figure 3B), which corresponds to the footprint of hA3G editing [31] and data in Figure 2. There is no clear-cut evidence for G-to-A substitutions in the GA and GT context, excluding any significant contribution of hA3B, hA3DE or hA3F. Noteworthily, a "non-specific" bias can be observed for the endogenous IAPE-A, -D and HERV-K elements, which favors G-to-A mutations in CG dinucleotides (Figure 3B), most probably reflecting an APOBEC3-independent (since it is also observed for the duplicated IAPE-A elements) deamination of methylated-CpG islands. Finally, examples of sub-genomic regions of IAPE-D and HERV-K elements enriched in G-to-A substitutions, are shown in Figure 3C, where the di- or tri-nucleotide sequences specific for the hA3G and mA3 APOBEC proteins, respectively, are underlined. Altogether, these in silico data strongly suggest that the IAPE and HERV-K elements have been subjected to editing by specific APOBEC3 proteins during their retroviral cycle of amplification and insertion into their target host genome.
###end p 18
###begin p 19
###xml 63 69 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
###xml 111 116 <span type="species:ncbi:9606">human</span>
###xml 171 176 <span type="species:ncbi:10090">mouse</span>
###xml 185 190 <span type="species:ncbi:9606">human</span>
###xml 353 359 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 583 589 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 1119 1125 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 1341 1347 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 1468 1474 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
Distribution of the nucleotide substitutions in the IAPE-D and HERV-K genomic copies residing in the mouse and human genomes. Endogenous sequences were extracted from the mouse and the human genome databases, aligned and compared to the derived consensus. (A) Upper panels: percentage of substitutions for each nucleotide, for the endogenous IAPE-D and HERV-K elements (with the IAPE-A elements used as a control). Lower panels: two-entry tables showing nucleotide substitutions preferences, with the G-to-A values in bold (higher that the "non-specific" C-to-T value for IAPE-D and HERV-K, and identical in the case of the IAPE-A control). n, total number of nucleotides analyzed. (B) Influence of nucleotides at position -2, -1, +1 and +2 on G-to-A mutations (the mutated G is at position 0). Data represent the percentage of indicated target di- or trinucleotide sequences bearing G-to-A mutations. X represents any nucleotide. P-values calculated for the two-entry tables (in A) by a Poisson regression in a log-linear model for the occurrence of the G-to-A versus C-to-T mutations yielded p < 0.003 for IAPE-D and HERV-K; in B, p-values calculated by a chi square test were p < 0.001; similar levels of significance were obtained using the Kruskal Wallis test. (C) Example of G-to-A mutations present in twenty IAPE-D (upper panel) and HERV-K (lower panel) sequences. GXA trinucleotides and GG dinucleotides are underlined in the consensus sequence of IAPE-D and HERV-K, respectively.
###end p 19
###begin p 20
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A&#8211;B</xref>
###xml 567 571 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A&#8211;B</xref>
###xml 1174 1175 1174 1175 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 1595 1596 1595 1596 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 1705 1709 1705 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B&#8211;C</xref>
###xml 1756 1757 1756 1757 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 1850 1852 1850 1852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 159 165 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 936 942 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 1204 1210 <span type="species:ncbi:10090">murine</span>
###xml 1368 1373 <span type="species:ncbi:9606">human</span>
###xml 1390 1396 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 1534 1540 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 1883 1889 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 1988 1994 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 2016 2021 <span type="species:ncbi:9606">human</span>
We further explored APOBEC3 editing by analyzing more specifically the G-to-A substitutions at the mA3 and hA3G target sites for each of the twenty IAPE-D and HERV-K proviruses, respectively. As shown in Figure 4A-B, for each proviral element, both the total number of G-to-A mutations (grey plus hatched grey) and the number of G-to-A mutations at the mA3- and hA3G-specific sites (hatched grey) were measured, together with the number of C-to-T "non-strand-specific" mutations as an internal control (dark bars; also used to order the copies in the Figure). Figure 4A-B then clearly shows that i) the total number of G-to-A mutations is for most proviruses higher than that of the "control" C-to-T mutations, ii) this increase is essentially due to "specific" mutations at the respective APOBEC3 sites, and iii) the extent of the observed mutations is highly variable depending on the proviral copy. Actually, for both the IAPE-D and HERV-K proviruses, more G-to-A mutations than C-to-T mutations can be observed, consistent with a strand specificity that can only have occurred prior to integration; in addition, this excess of G-to-A mutations is in general observed at GXA triplet positions for the murine, mA3-sensitive IAPE-D (> 40% of the G-to-A mutations for the majority of the proviruses, namely thirteen out of twenty), and at GG doublet positions for the human, hA3G-sensitive HERV-K elements. For the latter, it should be noted that the extent of specific G-to-A mutations is rather limited (seventeen out of the twenty HERV-K proviruses display < 30% of their G-to-A mutations at GG positions), except for two proviruses (ch3-1271 and ch21-0189) which are specifically hypermutated (Figure 4B-C), with > 70% of their G-to-A mutations in the GG context, without any evidence for a clear-cut gradient along the proviral sequence (Figure 4C). These results indicate that HERV-K can indeed be severely edited by hA3G, and that APOBEC3G protein expression at different times of HERV-K amplification in the human genome must have been quite variable.
###end p 20
###begin p 21
###xml 79 85 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 213 219 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 807 813 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
Variability of the number of G-to-A mutations within the endogenous IAPE-D and HERV-K proviruses depending on the element. The total numbers of G-to-A mutations (plain + hatched grey bars) for each IAPE-D (A) and HERV-K (B) proviruses are represented, together with that of the C-to-T (black bars) "none-strand-specific" mutations, given as an internal control (also used for ordering the elements) indicative of the genetic drift-associated age-dependent amount of mutations for each copy (same rank order as the sum of all non-G-to-A base substitutions). The number of G-to-A mutations specifically associated with the mA3 or hA3G APOBEC footprints is indicated with hatched grey. (C) Positioned G-to-A mutations (red bars) specifically associated with the hA3G APOBEC footprint ("GG") for the individual HERV-K elements in (B); yellow bars correspond to deletions in the proviruses (relative to the Phoenix consensus sequence). The data and the image shown in figure 4C were generated using the Hypermut 2.0 software available at the  website.
###end p 21
###begin title 22
Conclusion
###end title 22
###begin p 23
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 382 390 382 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 404 414 404 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1876 1877 1876 1877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1890 1900 1890 1900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 243 248 <span type="species:ncbi:4932">yeast</span>
###xml 291 297 <span type="species:ncbi:10090">murine</span>
###xml 712 718 <span type="species:ncbi:10090">murine</span>
###xml 729 735 <span type="species:ncbi:10090">murine</span>
###xml 764 769 <span type="species:ncbi:9606">human</span>
###xml 770 776 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 790 795 <span type="species:ncbi:9606">human</span>
###xml 1335 1340 <span type="species:ncbi:9606">human</span>
###xml 1370 1376 <span type="species:ncbi:10090">murine</span>
The restriction effects of APOBEC proteins on endogenous retroelements have essentially concerned retrotransposons with a strictly intracellular life cycle, namely the LINE/SINE non-LTR retrotransposons, and LTR-retrotransposons including the yeast Ty1 element [36,37], and the IAP and MusD murine elements [3,24,26,33]. In these cases severe restriction has been observed, both in ex vivo assays and by in silico analysis of the traces that APOBEC proteins have left through DNA edition in the course of reverse transcription of the retroelements [26]. Here we show that similar effects take place at the level of endogenous retroviruses with an extracellular life cycle, with an unambiguous restriction of the murine IAPE by a murine APOBEC3 protein, and of the human HERV-K element by a human APOBEC3 protein. Taking into account that an infectious IAPE retrovirus with an extracellular life cycle has been the progenitor of the IAP element, the restriction observed for IAP by mA3 appears simply to be the consequence of the restriction that initially controlled the progenitor infectious IAPE invading the rodent ancestor, with the effect being maintained in the evolution of the endogenized IAP retroelements. Although it concerns a heterologous - and therefore not necessarily very relevant-situation, it is noteworthy that the human hA3A protein can control the murine intracellular IAP retroelement, a property not observed for the IAPE infectious progenitor. This is most probably relevant to the localization of the hA3A protein - in the nucleus - and to its rather atypical mode of action - not involving editing of the reverse transcribed DNA - which identifies this restriction factor as more specifically devoted to intracellular retrotransposons, consistent with the absence of reported effects of this factor on - most - infectious retroviruses (reviewed in [2]). Finally, in silico analysis of the genomic copies of the elements demonstrates that APOBEC3 editing has taken place in evolution for these amplified elements, with clear-cut evidence for a severe heterogeneity in the extent of the editing process.
###end p 23
###begin title 24
Methods
###end title 24
###begin title 25
Plasmids
###end title 25
###begin p 26
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 251 254 251 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TNF</sup>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 11 17 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 23 29 <span type="species:ncbi:10090">murine</span>
###xml 66 69 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 206 212 <span type="species:ncbi:10090">murine</span>
The human (HERV-K) and murine (IAPE-D) neo-marked ERV copies (pBS CMV-Kcons Stop Env neoAS and pCMV RU5 IAPE neoAS, respectively), the VSV-G and IAPE-D env expression vectors, and the neo-marked autonomous murine IAP retrotransposon (pGL3-IAP92L23 neoTNF) have been previously described [17-19]. The APOBEC3 expression plasmids were obtained from M. Malim (hA3A), the NIH AIDS Research and Reference Reagent program (hA3B, hA3C and hA3F), Open Biosystems (hA3DE), A. Hance (hA3G), and N. Landau (mA3). A plasmid expressing a defective hA3G gene (with a premature stop codon) was used as a negative control. All the APOBEC3 ORF-containing fragments were re-cloned into the pcDNA6 expression plasmid (Invitrogen).
###end p 26
###begin title 27
Retrotransposition and infection assays
###end title 27
###begin p 28
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 237 240 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 248 251 247 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env</italic>
###xml 312 316 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 741 743 730 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R </sup>
###xml 773 775 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 776 778 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 262 268 <span type="species:ncbi:10090">murine</span>
###xml 272 277 <span type="species:ncbi:9606">human</span>
Retrotransposition assays with the neo-marked IAP were as described previously [38]. For the infection assays, 293T cells seeded in 60-mm-diameter plates were transfected using the Lipofectamine Plus kit (Invitrogen) with 4.5 mug of the neo-marked env-defective murine or human ERV, 0.5 mug of the IAPE or VSV-G env expression vector, and 5 mug of the APOBEC3 expression vector to be tested. Supernatants were harvested 48 h post-transfection, filtered through 0.45-mum pore-size PVDF membranes, supplemented with Polybrene (4 mug/ml), and used to infect HeLa target cells by spinoculation (1.200 g for 2.5 h at 25degreesC). Infection events were detected upon G418 selection of target cells and viral titers quantified as the number of G418R clones per mL of supernatant [18,19].
###end p 28
###begin title 29
Analysis of integrated proviral DNAs
###end title 29
###begin p 30
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R </sup>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag </italic>
###xml 525 529 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
###xml 248 254 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 775 781 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
Cellular DNA from 20-25 individual G418R clones was used to PCR-amplify a 996 bp fragment encompassing the env to neo gene region (nt 6783-7779) of the IAPE-D element and a 2049 bp fragment spanning the neo to gag gene region (nt 1093-3142) of the HERV-K element (initial 3 min denaturation step at 94degreesC; 40 cycles: 94degreesC, 50 sec; 60degreesC, 50 sec; 68degreesC, 150 sec). PCR reactions were performed with sets of appropriate primers in 50 mul containing 0.5 mug of cellular DNA, 1x Buffer II and 1.5 U AccuPrime Taq DNA polymerase (Invitrogen). The PCR products were electrophoresed on agarose gels, purified with the Nucleospin Extract II kit (Macherey-Nagel) and a ~800 bp or a ~1600 bp fragment was sequenced (Applied Biosystem sequencing kit) for IAPE-D and HERV-K, respectively.
###end p 30
###begin title 31
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 15 <span type="species:ncbi:10090">Mouse</span>
Human and Mouse genome analyses
###end title 31
###begin p 32
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag</italic>
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pol </italic>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1216 1217 1216 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 19 25 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
###xml 117 122 <span type="species:ncbi:10090">Mouse</span>
###xml 166 171 <span type="species:ncbi:9606">Human</span>
###xml 428 434 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 612 618 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 978 984 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 1163 1168 <span type="species:ncbi:10090">mouse</span>
###xml 1173 1178 <span type="species:ncbi:9606">human</span>
IAPE-D, IAPE-A and HERV-K endogenous retroviruses were extracted from the mouse and human genome sequence databases (Mouse GoldenPath mm8, February 2006 assembly and Human GoldenPath hg18, March 2006 assembly; ) by using as a querying probe the sequence of the previously described functional IAPE-D1 copy [18], the sequence of the IAPE-A copy with intact gag-pol open reading frames (chr14-0436, [18]), and the sequence of the HERV-K element (Phoenix-derived; [19]) used in the cell-based infection assay. Twenty sequences displaying the highest homology to their cognate probe were selected for the IAPE-D and HERV-K elements. Twenty sequences with the highest homology to the IAPE-A sequence and localized on the Y chromosome were also selected to be used as a control (see Results). Alignments were performed using the ClustalW and Editsequence softwares and consensus sequences generated. Quantitative analysis of the nucleotide substitutions within the IAPE-A, IAPE-D and HERV-K elements was performed using Excel and Hypermut 2.0 (available at the  website) softwares, on the full-length retroviruses. The localization of the analyzed sequences within the mouse and human genomes are given in additional file 1.
###end p 32
###begin title 33
Statistical analyses
###end title 33
###begin p 34
###xml 44 45 44 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 50 51 50 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 458 464 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
Significance levels for the data in Figures 2 and 3 were calculated using the Kruskal Wallis test (GrapPrism software package). More refined analyses for the occurrence of the G-to-A versus C-to-T mutations were performed using a Poisson regression in a log-linear model. The genmod procedure of the SAS software was used (version 9.1, SAS Institute Inc, Cary, NC). The observed distributions of the G-to-A mutations among the GA, GC, GG and GT contexts for HERV-K or the GXA, GXC, GXG and GXT contexts for IAPE were compared to the distribution of these di- or trinucleotides by the chi square test.
###end p 34
###begin title 35
Competing interests
###end title 35
###begin p 36
The authors declare that they have no competing interests.
###end p 36
###begin title 37
Authors' contributions
###end title 37
###begin p 38
###xml 93 103 93 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
CE, SP and DR carried out the experimental work and drafted the manuscript. OH performed the in silico analyses and drafted the manuscript. TH conceived the study and drafted the manuscript. All authors read and approved the final manuscript.
###end p 38
###begin title 39
Supplementary Material
###end title 39
###begin title 40
Additional file 1
###end title 40
###begin p 41
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
table 1. localization of the analyzed sequences within the mouse and human genomes.
###end p 41
###begin p 42
Click here for file
###end p 42
###begin title 43
Acknowledgements
###end title 43
###begin p 44
The authors wish to thank Anne Auperin for help in the statistical analyses and Christian Lavialle for critical reading of the manuscript. This work was supported by the CNRS, a grant from the Ligue Nationale contre le Cancer (Equipe labellisee) and fellowships from the CNRS to SP and the Association pour la Recherche sur le Cancer (ARC) to DR.
###end p 44
###begin article-title 45
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
###end article-title 45
###begin article-title 46
The APOBEC3 Cytidine Deaminases: An Innate Defensive Network Opposing Exogenous Retroviruses and Endogenous Retroelements
###end article-title 46
###begin article-title 47
###xml 34 56 <span type="species:ncbi:272636">adeno-associated virus</span>
APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons
###end article-title 47
###begin article-title 48
###xml 28 49 <span type="species:ncbi:11786">murine leukemia virus</span>
Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion
###end article-title 48
###begin article-title 49
###xml 47 76 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication
###end article-title 49
###begin article-title 50
###xml 70 75 <span type="species:ncbi:9606">human</span>
Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family
###end article-title 50
###begin article-title 51
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo
###end article-title 51
###begin article-title 52
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 69 74 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 79 84 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
###end article-title 52
###begin article-title 53
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 50 85 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication
###end article-title 53
###begin article-title 54
Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H
###end article-title 54
###begin article-title 55
APOBEC-mediated viral restriction: not simply editing?
###end article-title 55
###begin article-title 56
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
###end article-title 56
###begin article-title 57
###xml 39 44 <span type="species:ncbi:9606">human</span>
Initial sequencing and analysis of the human genome
###end article-title 57
###begin article-title 58
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Initial sequencing and comparative analysis of the mouse genome
###end article-title 58
###begin article-title 59
###xml 10 16 <span type="species:ncbi:10090">murine</span>
An active murine transposon family pair: retrotransposition of "master" MusD copies and ETn trans-mobilization
###end article-title 59
###begin article-title 60
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine MusD retrotransposon: structure and molecular evolution of an "intracellularized" retrovirus
###end article-title 60
###begin article-title 61
Identification of autonomous IAP LTR retrotransposons mobile in mammalian cells
###end article-title 61
###begin article-title 62
###xml 33 39 <span type="species:ncbi:10090">murine</span>
An infectious progenitor for the murine IAP retrotransposon: emergence of an intracellular genetic parasite from an ancient retrovirus
###end article-title 62
###begin article-title 63
###xml 65 71 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 72 77 <span type="species:ncbi:9606">human</span>
Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements
###end article-title 63
###begin article-title 64
###xml 32 59 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Reconstitution of an infectious human endogenous retrovirus
###end article-title 64
###begin article-title 65
###xml 25 30 <span type="species:ncbi:9606">human</span>
APOBEC3 proteins inhibit human LINE-1 retrotransposition
###end article-title 65
###begin article-title 66
APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism
###end article-title 66
###begin article-title 67
LINE-mediated retrotransposition of marked Alu sequences
###end article-title 67
###begin article-title 68
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition
###end article-title 68
###begin article-title 69
###xml 58 63 <span type="species:ncbi:9606">human</span>
The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay
###end article-title 69
###begin article-title 70
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses
###end article-title 70
###begin article-title 71
Selective inhibition of Alu retrotransposition by APOBEC3G
###end article-title 71
###begin article-title 72
High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition
###end article-title 72
###begin article-title 73
###xml 79 84 <span type="species:ncbi:9606">human</span>
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
###end article-title 73
###begin article-title 74
###xml 54 77 <span type="species:ncbi:11786">murine leukemia viruses</span>
Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses
###end article-title 74
###begin article-title 75
###xml 83 86 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
###end article-title 75
###begin article-title 76
Cytidine deamination of retroviral DNA by diverse APOBEC proteins
###end article-title 76
###begin article-title 77
Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses
###end article-title 77
###begin article-title 78
###xml 84 96 <span type="species:ncbi:10090">Mus musculus</span>
Co-amplification to tail-to-tail copies of MuRVY and IAPE retroviral genomes on the Mus musculus Y chromosome
###end article-title 78
###begin article-title 79
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Genetics of intracisternal-A-particle-related envelope-encoding proviral elements in mice
###end article-title 79
###begin article-title 80
###xml 16 21 <span type="species:ncbi:4932">yeast</span>
###xml 45 50 <span type="species:ncbi:9606">human</span>
Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases
###end article-title 80
###begin article-title 81
###xml 73 78 <span type="species:ncbi:4932">yeast</span>
APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast
###end article-title 81
###begin article-title 82
###xml 2 25 <span type="species:ncbi:5911">Tetrahymena thermophila</span>
A Tetrahymena thermophila ribozyme-based indicator gene to detect transposition of marked retroelements in mammalian cells
###end article-title 82

